Tvardi Therapeutics
Joseph Chen, Ph.D. brings 25 years of experience in CMC development of drug substances and products. Dr. Chen has extensive expertise in both technical leadership and management oversight in CMC development and manufacturing in-house and/or at CMO’s. Prior to joining Tvardi, he worked at Boehringer Ingelheim, Tanox, Johnson-Johnson, and Lexicon Pharmaceuticals in positions of increasing responsibilities, leading CMC development for multiple pharmaceutical/biological products. He has provided leadership and strategic planning for all aspects of CMC development including technical, manufacturing, and regulatory aspects of pharmaceutical development of drug substances and drug products at all phases. Dr. Chen holds B.S. and M.S degrees in chemical engineering from Tianjin University, China, and a Ph.D. in analytical chemistry from the University of Memphis, Tennessee.
This person is not in any teams
This person is not in any offices
Tvardi Therapeutics
1 followers
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.